Ethnic aspects of cancer trials in Asia.
New drugs which have potential in cancer therapy are emerging every day and there is an increasing demand for trial patients all over the world. Asia being the most populated continent, as well as a large market for drug sales, has its own epidemiology of disease. The Asian races also have specific genomics that might affect response to drug treatment. In addition, there are cultural issues to be considered when considering clinical trials. In conclusion, more clinical trials should be done among Asian populations for the best results of drug treatment.
Leung
T W T
TW
Comprehensive Oncology Centre, Hong Kong Sanatorium and Hospital, SAR China. thomaswtleung@hksh.com
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001208:Asia; D044466:Asian People; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004777:Environment; D005006:Ethnicity; D006801:Humans; D009369:Neoplasms / Q000453:epidemiology* / Q000208:ethnology*; D018579:Patient Selection; D012107:Research Design
D000970:Antineoplastic Agents